Biological activity of a polypeptide modulator of TRPV1 receptor

被引:6
|
作者
Dyachenko I.A. [1 ]
Andreev Y.A. [2 ]
Logashina Y.A. [2 ]
Murashev A.N. [1 ]
Grishin E.V. [2 ]
机构
[1] Pushchino Branch, Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Pushchino, Moscow oblast
[2] Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow
基金
俄罗斯科学基金会;
关键词
Capsaicin; Transient Receptor Potential Vanilloid; Analgesic Activity; Cyanogen Bromide; Vanilloid Receptor;
D O I
10.1134/S0012496615060034
中图分类号
学科分类号
摘要
This paper presents data on the activity of a new APHC2 polypeptide modulator of TRPV1 receptors, which was isolated from the sea anemone Heteractis crispa. It has been shown that APHC2 has an analgesic activity, does not impair normal motor activity, and does not change body temperature of experimental animals, which has a great practical value for design of potent analgesics of a new generation. Further study of the characteristics of binding of the polypeptide to the TRPV1 receptor may show approaches to the development of other antagonists of this receptor that do not influence the body temperature. © 2015, Pleiades Publishing, Ltd.
引用
收藏
页码:279 / 281
页数:2
相关论文
共 50 条
  • [11] ANANDAMIDE AND THE VANILLOID RECEPTOR (TRPV1)
    Toth, Attila
    Blumberg, Peter M.
    Boczan, Judit
    VITAMINS AND HORMONES: ANANDAMIDE AN ENDOGENOUS CANNABINOID, 2009, 81 : 389 - 419
  • [12] Synthesis and Vanilloid Receptor (TRPV1) Activity of the Enantiomers of α-Fluorinated Capsaicin
    Winkler, Margit
    Moraux, Thomas
    Khairy, Hesham A.
    Scott, Roderick H.
    Slawin, Alexandra M. Z.
    O'Hagan, David
    CHEMBIOCHEM, 2009, 10 (05) : 823 - 828
  • [13] Polypeptide Modulators of TRPV1 Produce Analgesia without Hyperthermia
    Andreev, Yaroslav A.
    Kozlov, Sergey A.
    Korolkova, Yuliya V.
    Dyachenko, Igor A.
    Bondarenko, Dmitrii A.
    Skobtsov, Denis I.
    Murashev, Arkadii N.
    Kotova, Polina D.
    Rogachevskaja, Olga A.
    Kabanova, Natalia V.
    Kolesnikov, Stanislav S.
    Grishin, Eugene V.
    MARINE DRUGS, 2013, 11 (12): : 5100 - 5115
  • [14] Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade
    Gavva, Narender R.
    Bannon, Anthony W.
    Hovland, David N., Jr.
    Lehto, Sonya G.
    Klionsky, Lana
    Surapaneni, Sekhar
    Immke, David C.
    Henley, Charles
    Arik, Leyla
    Bak, Annette
    Davis, James
    Ernst, Nadia
    Hever, Gal
    Kuang, Rongzhen
    Shi, Licheng
    Tamir, Rami
    Wang, Jue
    Wang, Weiya
    Zajic, Gary
    Zhu, Dawn
    Norman, Mark H.
    Louis, Jean-Claude
    Magal, Ella
    Treanor, James J. S.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (01): : 128 - 137
  • [15] Monoacylglycerols activate capsaicin receptor, TRPV1
    Iwasaki, Yusaku
    Saito, Orine
    Tanabe, Manabu
    Inayoshi, Kimiko
    Kobata, Kenji
    Uno, Shuichi
    Morita, Akihito
    Watanabe, Tatsuo
    LIPIDS, 2008, 43 (06) : 471 - 483
  • [16] The Role of the TRPV1 Receptor in Pain and Inflammation
    不详
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2011, 39 (03): : 211 - 212
  • [17] Novel, potent TRPV1 receptor antagonists
    Brown, Brian S.
    Keddy, Ryan G.
    Zheng, Guo Zhu
    Schmidt, Robert G.
    Koenig, John Robert
    Honore, Prisca
    Jarvis, Michael F.
    Surowy, Carol S.
    Faltynek, Connie R.
    Lee, Chih-Hung
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2545 - U2546
  • [18] The TRPV1 receptor: Target of toxicants and therapeutics
    Veronesi, B
    Oortgiesen, M
    TOXICOLOGICAL SCIENCES, 2006, 89 (01) : 1 - 3
  • [19] Structure-activity relationships of vanilloid receptor agonists for arteriolar TRPV1
    Czikora, A.
    Lizanecz, E.
    Bako, P.
    Rutkai, I.
    Ruzsnavszky, F.
    Magyar, J.
    Porszasz, R.
    Kark, T.
    Facsko, A.
    Papp, Z.
    Edes, I.
    Toth, A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (06) : 1801 - 1812
  • [20] TRPV1 (vanilloid receptor, capsaicin receptor) agonists and antagonists
    Appendino, G
    Muñoz, E
    Fiebich, BL
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (12) : 1825 - 1837